Characteristics | Total (N = 168) | DIH (n = 20) | Non-DIH (n = 148) | P-value |
---|---|---|---|---|
Total treatment duration, days | 243.4 ± 97.5 | 243.9 ± 81.5 | 243.3 ± 99.7 | 0.964 |
Actual treatment duration/planned treatment duration | 1.14 ± 0.51 | 1.26 ± 0.48 | 1.13 ± 0.52 | 0.392 |
Treatment interruption period/total treatment duration | 0.02 ± 0.06 | 0.04 ± 0.06 | 0.01 ± 0.04 | < 0.001 |
Sputum culture conversion (solid) (n = 155) | 155 (99.4) | 20 (100.0) | 135 (99.3) | 0.587 |
Sputum culture conversion (liquid) (n = 162) | 158 (98.1) | 19 (100.0) | 140 (97.9) | 0.522 |
Time to sputum culture conversion (solid), days (n = 155) | 47.0 ± 31.3 | 47.1 ± 26.1 | 47.0 ± 32.1 | 0.993 |
Time to sputum culture conversion (liquid), days (n = 162) | 67.2 ± 96.8 | 64.0 ± 56.0 | 67.6 ± 101.2 | 0.859 |
2-month sputum culture conversion (solid) (n = 155) | 129 (82.7) | 16 (80.0) | 113 (83.1) | 0.787 |
2-month sputum culture conversion (liquid) (n = 162) | 117 (73.1) | 13 (68.4) | 104 (73.8) | 0.658 |
Treatment outcome | ||||
Treatment completion | 106 (63.1) | 14 (70.0) | 92 (62.2) | 0.495 |
Cure | 54 (32.1) | 3 (15.0) | 51 (34.5) | 0.080 |
Treatment success | 160 (95.2) | 17 (85.0) | 143 (96.6) | 0.022 |
TB-related mortality | 0 (0) | 0 (0) | 0 (0) | 1.0 |
All-cause mortality | 8 (4.8) | 3 (15.0) | 5 (3.4) | 0.055 |
Recurrence within 1 year (n = 148) | 7 (4.2) | 2 (10) | 5 (3.4) | 0.196 |